AlphaCore Capital LLC

Position in ABBV — AbbVie Inc.

CIK 1713662 LA JOLLA, CA

Position in ABBV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$11,443,580

+$3,934,738 QoQ

Shares Held

45,476

+31.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.56%

of 13F equity value

Holder Rank

#857

of 4,153 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

AlphaCore Capital LLC holds $65,400,986 across 13 Drug Manufacturers - General names. ABBV ranks #3 (17.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,692	$16,422,596
2	JNJ	Johnson & Johnson	50,226	$12,755,897
3	ABBV	AbbVie Inc. This page	45,476	$11,443,580
4	MRK	Merck & Co., Inc.	51,249	$6,585,496
5	PFE	Pfizer Inc	208,486	$5,020,342
6	AMGN	Amgen Inc	13,140	$4,758,256
7	BMY	Bristol Myers Squibb Co	46,389	$2,672,934
8	GILD	Gilead Sciences, Inc.	16,707	$2,110,762

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,443,580	45,476	+31.7%	Shares	Sole	2026-08-06
2026-03-31	$7,508,842	34,525	+3.3%	Shares	Sole	2026-05-15
2025-12-31	$7,637,963	33,428	+9.4%	Shares	Sole	2026-02-05
2025-09-30	$7,073,778	30,551	+9.0%	Shares	Sole	2025-11-12
2025-06-30	$5,202,742	28,029	+17.5%	Shares	Sole	2025-08-12
2025-03-31	$4,996,423	23,847	+22.2%	Shares	Sole	2025-05-12
2024-12-31	$3,466,749	19,509	+0.9%	Shares	Sole	2025-02-21
2024-09-30	$3,816,695	19,327	+0.2%	Shares	Sole	2024-11-12
2024-06-30	$3,307,763	19,285	-2.0%	Shares	Sole	2024-08-14
2024-03-31	$3,581,907	19,670	+0.0%	Shares	Sole	2024-05-15
2023-12-31	$3,047,794	19,667	+3.5%	Shares	Sole	2024-02-13
2023-09-30	$2,832,885	19,005	+1.6%	Shares	Sole	2023-11-13
2023-06-30	$2,519,316	18,699	+12449.7%	Shares	Sole	2023-08-10
2020-03-31	$11,352	149	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.